Loading…
Novo Nordisk xStock (NVOX) Price Prediction 2026–2050
Rank #3265Bullish
$48.79
+0.96% (24h)
Novo Nordisk xStock (NVOX) Forecast Summary
Novo Nordisk xStock is projected to rise to $84.75 by 2027, a +74% move from its current price of $48.79. NVOX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy. Market sentiment sits at 26/100 (Fear) on the Fear & Greed Index.
A data-driven summary — not financial advice. See the full breakdown below.
Tokenized AssetsBNB Chain EcosystemSolana EcosystemTokenized StockEthereum EcosystemReal World Assets (RWA)BackedFi xStocks Ecosystem
Live market data via CoinGecko & CoinMarketCap · updated 7/1/2026
Market Cap
$639.37K
24h Volume
$846.48
Circulating Supply
13.1K NVOX
All-Time High
$66.15
Green Days (30d)
12/30
Volatility (30d)
3.17%
Novo Nordisk xStock (NVOX) Price Prediction Summary
Crypto Fear & Greed Index
Market sentiment today26Fear
Extreme FearNeutralExtreme Greed
NVOX Short-Term Price Forecast
Next 7 days
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $47.80 | $48.85 | $49.93 | +0.13% |
| Jul 14 | $47.43 | $48.92 | $50.44 | +0.26% |
| Jul 15 | $47.17 | $48.98 | $50.86 | +0.38% |
| Jul 16 | $46.95 | $49.04 | $51.22 | +0.51% |
| Jul 17 | $46.77 | $49.10 | $51.55 | +0.64% |
| Jul 18 | $46.61 | $49.17 | $51.86 | +0.77% |
| Jul 19 | $46.47 | $49.23 | $52.15 | +0.90% |
Next 7 weeks
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $46.47 | $49.23 | $52.15 | +0.90% |
| Week 2 | $45.79 | $49.67 | $53.89 | +1.81% |
| Week 3 | $45.36 | $50.12 | $55.38 | +2.72% |
| Week 4 | $45.07 | $50.57 | $56.74 | +3.65% |
| Week 5 | $44.86 | $51.03 | $58.04 | +4.58% |
| Week 6 | $44.71 | $51.48 | $59.29 | +5.52% |
| Week 7 | $44.60 | $51.95 | $60.50 | +6.47% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
What is Novo Nordisk xStock (NVOX)?
Novo Nordisk xStock (NVOX) is a tokenized stock that represents the value of Novo Nordisk within the xStocks ecosystem. xStocks are tokenized stocks that are backed 1:1 by the underlying assets and provide a legal claim to the value of the stock. They are designed to be composable with DeFi protocols, compliant with EU regulations, and accessible to non-US users.
Novo Nordisk xStock sits among tokenized assets that enable regular users to access stocks and ETFs through top centralized and decentralized exchanges, bringing public equity exposure into the tokenized asset space.
Novo Nordisk xStock Price Prediction Overview
Novo Nordisk xStock (NVOX) is currently priced at $48.79 with a market cap of $639.37K and a rank of 3265. The asset’s all-time high is $66.15 and its all-time low is $34.26. These figures provide context for its volatility and historical trading range.
The near-term technical picture shows a bullish tilt, with a 30-day range of $43.31 to $54.97 and a current price hovering near key levels. The asset’s RSI stands at 70, and the SMA50 is $44.88 while the SMA200 is $45.95, indicating momentum above its short- and longer-term moving averages. The forecast horizon spans 2026 through 2050, outlining a rising trajectory with year-by-year Avg prices and ROI, including a 2026 avg of $48.79 and a long-term view culminating in 2050 with an avg of $7,058.99 and a max of $13,605.79, signaling substantial upside over time.
NVOX Market & Technical Analysis
NVOX Key Price Levels
Strong Support−25.7%
$36.27
A major floor 25.7% below — a decisive break under it would weaken the trend.
Current Support−15.7%
$41.14
The nearest floor, 15.7% below — buyers have tended to step in here.
Current Resistance+0.0%
$48.79
Price is pressing into resistance (0.0% away) — a breakout level to watch.
Strong Resistance+10.5%
$53.90
A major ceiling 10.5% above — clearing it would confirm fresh momentum.
Key NVOX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
NVOX Market Analysis
Trend ConsensusBullish
Bullish share of indicators87%
Timeframe AlignmentStrong
Price above 12/12 moving averages100%
Risk AssessmentLower
~42% annualised volatility35%
Momentum (RSI)Buyers
RSI 69 — buying vs selling pressure69%
A snapshot of NVOX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
NVOX Indicator Summary
Strong Buy
Based on 26 indicators
- Buy
- 20
- Neutral
- 3
- Sell
- 3
Bearish87% BullishBullish
Indicators computed on daily closing prices.
Moving Averages
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $48.03 | Buy | $47.95 | Buy |
| MA 10 | $47.38 | Buy | $47.20 | Buy |
| MA 20 | $45.57 | Buy | $46.16 | Buy |
| MA 50 | $44.94 | Buy | $44.84 | Buy |
| MA 100 | $42.35 | Buy | $44.24 | Buy |
| MA 200 | $45.96 | Buy | $45.01 | Buy |
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI (14) | 67.30 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 118.56 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.36 | Buy |
| ROC (12) | 12.05 | Buy |
| Bollinger %B (20,2) | 0.90 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 0.24 | Buy |
| Awesome (5,34) | 3.16 | Buy |
| Ultimate (7,14,28) | 77.22 | Sell |
| Momentum (10) | 6.04 | Buy |
| Aroon Osc (25) | 84.00 | Buy |
| Hull MA (9) | 48.19 | Buy |
| ADX (14) | 19.96 | Neutral |
| ATR (14) | 0.68 | Info |
Pivot Levels
- S3$36.04
- S2$38.59
- S1$43.69
- Pivot$46.24
- R1$51.35
- R2$53.90
- R3$59.00
The 30-day technical picture is bullish. RSI(14) is 70, supporting positive momentum alongside a price above both the 50-day and 200-day simple moving averages, which are $44.88 and $45.95 respectively. The current resistance level is $48.79 and support sits at $41.14, with a 30-day price range of $43.31 to $54.97.
This structure suggests ongoing upward pressure, though near-term moves may test the $48.79 resistance as momentum ebbs and flows within the 30-day window.
Novo Nordisk xStock (NVOX) Price Prediction 2026–2050
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $35.48 | $48.79 | $64.95 | 0% | Neutral | |
| $66.69 | $84.75 | $114.42 | +74% | Bullish | |
| $129.59 | $169.92 | $238.80 | +248% | Bullish | |
| $176.81 | $237.96 | $345.09 | +388% | Bullish | |
| $147.40 | $203.01 | $302.28 | +316% | Bullish | |
| $249.01 | $350.28 | $533.72 | +618% | Bullish | |
| $513.69 | $737.00 | $1,146.33 | +14.1x | Bullish | |
| $431.99 | $631.39 | $1,000.56 | +11.9x | Bullish | |
| $417.36 | $620.88 | $1,000.92 | +11.7x | Bullish | |
| $832.73 | $1,259.98 | $2,063.75 | +24.8x | Bullish | |
| $2,136.09 | $3,492.19 | $6,112.92 | +70.6x | Bullish | |
| $3,771.23 | $7,058.99 | $13,605.79 | +143.7x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
Novo Nordisk xStock (NVOX) 2026 Monthly Forecast
Current Price $48.79Range $35.48 – $64.950% ROI
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $35.48 | $48.79 | $60.93 | +0.00% |
| August 2026 | $47.21 | $56.07 | $68.62 | +14.92% |
| September 2026 | $45.84 | $54.83 | $67.87 | -2.21% |
| October 2026 | $40.67 | $48.96 | $61.20 | -10.70% |
| November 2026 | $40.82 | $49.41 | $62.27 | +0.91% |
| December 2026 | $42.03 | $51.14 | $64.95 | +3.51% |
Click any year to see its month-by-month NVOX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Novo Nordisk xStock (NVOX) Year-by-Year Price Prediction
Novo Nordisk xStock (NVOX) Price Prediction 2026
By 2026, NVOX could reach as high as $64.95, with a base case around $48.79 and support toward $35.48 — roughly 0% from $48.79. Price action looks broadly range-bound.
Novo Nordisk xStock (NVOX) Price Prediction 2027
Expect NVOX to range from $66.69 to $114.42 through 2027. The $84.75 average target implies a +74% move from current prices. That is up +74% on the projected 2026 average. Buyers look set to stay in control over this stretch.
Novo Nordisk xStock (NVOX) Price Prediction 2028
The NVOX price prediction for 2028 points to an average of $169.92 (low $129.59, high $238.80) — a potential gain of +248% on today's $48.79. Momentum favours further upside here.
Novo Nordisk xStock (NVOX) Price Prediction 2029
In 2029, NVOX is projected to trade between $176.81 and $345.09, averaging $237.96 — a potential gain of +388% from today's $48.79. That is up +40% on the projected 2028 average. Buyers look set to stay in control over this stretch.
Novo Nordisk xStock (NVOX) Price Prediction 2030
Novo Nordisk xStock's 2030 outlook centres on $203.01, within a $147.40 to $302.28 range. That is -15% versus the projected 2029 average. That marks a +316% change versus current levels. Momentum favours further upside here.
Novo Nordisk xStock (NVOX) Price Prediction 2031
By 2031, NVOX could reach as high as $533.72, with a base case around $350.28 and support toward $249.01 — roughly +618% from $48.79. Buyers look set to stay in control over this stretch.
Novo Nordisk xStock (NVOX) Price Prediction 2032
Expect NVOX to range from $513.69 to $1,146.33 through 2032. The $737.00 average target implies a +14.1x move from current prices. That is up +110% on the projected 2031 average. Momentum favours further upside here.
Novo Nordisk xStock (NVOX) Price Prediction 2033
The NVOX price prediction for 2033 points to an average of $631.39 (low $431.99, high $1,000.56) — a potential gain of +11.9x on today's $48.79. Buyers look set to stay in control over this stretch.
Novo Nordisk xStock (NVOX) Price Prediction 2034
In 2034, NVOX is projected to trade between $417.36 and $1,000.92, averaging $620.88 — a potential gain of +11.7x from today's $48.79. That is -2% versus the projected 2033 average. Momentum favours further upside here.
Novo Nordisk xStock (NVOX) Price Prediction 2035
Novo Nordisk xStock's 2035 outlook centres on $1,259.98, within a $832.73 to $2,063.75 range. That is up +103% on the projected 2034 average. That marks a +24.8x change versus current levels. Buyers look set to stay in control over this stretch.
Novo Nordisk xStock (NVOX) Price Prediction 2040
By 2040, NVOX could reach as high as $6,112.92, with a base case around $3,492.19 and support toward $2,136.09 — roughly +70.6x from $48.79. Momentum favours further upside here.
Novo Nordisk xStock (NVOX) Price Prediction 2050
Expect NVOX to range from $3,771.23 to $13,605.79 through 2050. The $7,058.99 average target implies a +143.7x move from current prices. That is up +102% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investment Calculator
Scenario
Investing $1,000 in NVOX today (≈ 20.496003 NVOX) could be worth
$144,681.17
+$143,681.17 (+14368%) by 2050 · US Dollar
Based on the average projected NVOX price of $7,058.99 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
NVOX tools
If You Had Invested in Novo Nordisk xStock
See what a past investment in NVOXwould be worth at today's price.
Invested
$1,000 invested in NVOX on Nov 20, 2025 (≈ 20.529665 NVOX) would be worth
$1,001.64
+$1.64 (+0.2%) today · 1.00× · US Dollar
Based on a NVOX entry price of $48.71 vs. today's $48.79.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $46.74 | $1,043.92 | +4.4% |
| 1 month ago | $45.78 | $1,065.82 | +6.6% |
| 3 months ago | $36.34 | $1,342.74 | +34.3% |
| 6 months ago | $51.1 | $954.82 | -4.5% |
| All time ago | $48.71 | $1,001.64 | +0.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Will NVOX reach a target price?
Enter a price to see how it sits against our NVOX forecast.
Likely(2.0× current price)
Our base-case forecast reaches $98.00 around 2028.
Implied market cap at $98.00: $1.28M
Novo Nordisk xStock Long-Term Forecast (2026–2050)
The multi-year forecast shows a bullish trajectory across most years, with rising averages and very high potential ROIs. For 2027 the avg is $84.75 with a bullish sentiment and a 73.7% ROI, followed by 2028’s avg $169.92 and 248.3% ROI, and 2029’s avg $237.96 with 387.7% ROI. By 2032 the avg is $737.00 with a 1,410.5% ROI, and the 2035 forecast reaches an avg of $1,259.98 with a 2,482.4% ROI.
The forecast continues to rise through 2040, showing an avg of $3,492.19 and a 7,057.6% ROI, and by 2050 the avg is $7,058.99 with a max of $13,605.79 and a 14,368.1% ROI. Overall, sentiment remains BULLISH across the long horizon, reflecting a strong growth path in the model’s projections. The asset exhibits higher volatility, with annualized volatility at 40%.
These estimates imply meaningful upside but also substantial risk and uncertainty. The numbers are forecasts, not guarantees, and actual results will depend on market conditions, broader adoption of tokenized stocks, and regulatory factors.
NVOX Frequently Asked Questions
Tap a question to reveal the answer.
What will Novo Nordisk xStock be worth in 2030?
The 2030 forecast shows an avg price of $203.01, with a min of $147.40 and a max of $302.28, and a ROI of 316.1%.
Is Novo Nordisk xStock a good investment?
The outlook is bullish in multiple years, with strong upside in 2027 (avg $84.75, ROI 73.7%) and increasingly higher targets through 2050 (avg $7,058.99, ROI 14,368.1%). These are estimates and not guarantees.
Can Novo Nordisk xStock reach $1,000?
Yes. The forecast shows a max of $1,146.33 in 2032 and $1,000.56 in 2033, indicating the possibility of surpassing $1,000 in the projection period.
What is the current price and market cap of Novo Nordisk xStock?
Current price is $48.79 and market cap is $639.37K.
What is the 30-day price range for Novo Nordisk xStock?
The 30-day range is $43.31 to $54.97.
Novo Nordisk xStock Community Discussion
0Share your Novo Nordisk xStock price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.